WO2000064407A1 - Absorbent tissues providing skin barrier enhancement - Google Patents
Absorbent tissues providing skin barrier enhancement Download PDFInfo
- Publication number
- WO2000064407A1 WO2000064407A1 PCT/US2000/011089 US0011089W WO0064407A1 WO 2000064407 A1 WO2000064407 A1 WO 2000064407A1 US 0011089 W US0011089 W US 0011089W WO 0064407 A1 WO0064407 A1 WO 0064407A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- composition
- weight percent
- product
- sterol
- Prior art date
Links
- 230000008591 skin barrier function Effects 0.000 title claims description 41
- 230000002745 absorbent Effects 0.000 title description 31
- 239000002250 absorbent Substances 0.000 title description 31
- 239000000203 mixture Substances 0.000 claims abstract description 220
- 229930182558 Sterol Natural products 0.000 claims abstract description 61
- 235000003702 sterols Nutrition 0.000 claims abstract description 61
- 150000003432 sterols Chemical class 0.000 claims abstract description 57
- 239000004094 surface-active agent Substances 0.000 claims abstract description 26
- 239000003974 emollient agent Substances 0.000 claims abstract description 25
- 239000003906 humectant Substances 0.000 claims abstract description 25
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 23
- 239000003623 enhancer Substances 0.000 claims abstract description 22
- 239000003921 oil Substances 0.000 claims description 104
- 235000019198 oils Nutrition 0.000 claims description 97
- 239000000047 product Substances 0.000 claims description 81
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 42
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical group CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 37
- 239000001993 wax Substances 0.000 claims description 34
- -1 polyethylene Polymers 0.000 claims description 30
- 239000003925 fat Substances 0.000 claims description 29
- 235000019197 fats Nutrition 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 26
- 239000004264 Petrolatum Substances 0.000 claims description 25
- 229940066842 petrolatum Drugs 0.000 claims description 25
- 235000019271 petrolatum Nutrition 0.000 claims description 25
- 230000008018 melting Effects 0.000 claims description 22
- 238000002844 melting Methods 0.000 claims description 22
- 230000035515 penetration Effects 0.000 claims description 22
- 235000011187 glycerol Nutrition 0.000 claims description 21
- 230000002708 enhancing effect Effects 0.000 claims description 18
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 17
- 229940033331 soy sterol Drugs 0.000 claims description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 229940012831 stearyl alcohol Drugs 0.000 claims description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 14
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- CWMMCBXYWVPWJL-FNORWQNLSA-N (e)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one Chemical group COC1=CC(OC)=CC=C1\C=C\C(=O)C1=C(O)C=C(O)C=C1OC CWMMCBXYWVPWJL-FNORWQNLSA-N 0.000 claims description 13
- CWMMCBXYWVPWJL-UHFFFAOYSA-N Cerasin Natural products COC1=CC(OC)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1OC CWMMCBXYWVPWJL-UHFFFAOYSA-N 0.000 claims description 13
- 235000019486 Sunflower oil Nutrition 0.000 claims description 13
- 239000002600 sunflower oil Substances 0.000 claims description 13
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical group C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 claims description 12
- 239000004698 Polyethylene Substances 0.000 claims description 11
- 229920000573 polyethylene Polymers 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 235000021302 avocado oil Nutrition 0.000 claims description 10
- 239000008163 avocado oil Substances 0.000 claims description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 10
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000004166 Lanolin Substances 0.000 claims description 9
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 9
- 239000004147 Sorbitan trioleate Substances 0.000 claims description 9
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 claims description 9
- 235000021324 borage oil Nutrition 0.000 claims description 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 9
- 235000019388 lanolin Nutrition 0.000 claims description 9
- 229940039717 lanolin Drugs 0.000 claims description 9
- 229950004959 sorbitan oleate Drugs 0.000 claims description 9
- 235000019337 sorbitan trioleate Nutrition 0.000 claims description 9
- 229960000391 sorbitan trioleate Drugs 0.000 claims description 9
- 235000012424 soybean oil Nutrition 0.000 claims description 9
- 239000003549 soybean oil Substances 0.000 claims description 9
- 230000008901 benefit Effects 0.000 claims description 8
- 239000004200 microcrystalline wax Substances 0.000 claims description 8
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 8
- 239000002480 mineral oil Substances 0.000 claims description 8
- 235000010446 mineral oil Nutrition 0.000 claims description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 7
- 235000012000 cholesterol Nutrition 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 7
- 229960000735 docosanol Drugs 0.000 claims description 7
- 150000003904 phospholipids Chemical class 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 235000010356 sorbitol Nutrition 0.000 claims description 7
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 6
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 6
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 6
- 239000005977 Ethylene Substances 0.000 claims description 6
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 claims description 6
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 6
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical group CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 6
- 239000004359 castor oil Substances 0.000 claims description 6
- 235000019438 castor oil Nutrition 0.000 claims description 6
- 229940107161 cholesterol Drugs 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 6
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 6
- 229950011392 sorbitan stearate Drugs 0.000 claims description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- 244000025272 Persea americana Species 0.000 claims description 5
- 235000008673 Persea americana Nutrition 0.000 claims description 5
- 229960000541 cetyl alcohol Drugs 0.000 claims description 5
- 235000019864 coconut oil Nutrition 0.000 claims description 5
- 239000003240 coconut oil Substances 0.000 claims description 5
- 235000012343 cottonseed oil Nutrition 0.000 claims description 5
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 5
- 229940075529 glyceryl stearate Drugs 0.000 claims description 5
- 239000010514 hydrogenated cottonseed oil Substances 0.000 claims description 5
- 229940043348 myristyl alcohol Drugs 0.000 claims description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 5
- 229920000098 polyolefin Polymers 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 5
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 claims description 4
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 claims description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 4
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 4
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 claims description 4
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 claims description 4
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 claims description 4
- 235000021314 Palmitic acid Nutrition 0.000 claims description 4
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 4
- 239000010480 babassu oil Substances 0.000 claims description 4
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 claims description 4
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims description 4
- 239000010495 camellia oil Substances 0.000 claims description 4
- 235000019519 canola oil Nutrition 0.000 claims description 4
- 239000000828 canola oil Substances 0.000 claims description 4
- 235000005687 corn oil Nutrition 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- 239000002385 cottonseed oil Substances 0.000 claims description 4
- 235000008524 evening primrose extract Nutrition 0.000 claims description 4
- 239000010475 evening primrose oil Substances 0.000 claims description 4
- 229940089020 evening primrose oil Drugs 0.000 claims description 4
- 239000012170 montan wax Substances 0.000 claims description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- 239000010667 rosehip oil Substances 0.000 claims description 4
- 235000005713 safflower oil Nutrition 0.000 claims description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims description 4
- 229950005143 sitosterol Drugs 0.000 claims description 4
- 235000015500 sitosterol Nutrition 0.000 claims description 4
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims description 4
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 claims description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 3
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 claims description 3
- 241001072282 Limnanthes Species 0.000 claims description 3
- 244000042664 Matricaria chamomilla Species 0.000 claims description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 3
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000010477 apricot oil Substances 0.000 claims description 3
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 3
- 230000001010 compromised effect Effects 0.000 claims description 3
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229940042472 mineral oil Drugs 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000001540 sodium lactate Substances 0.000 claims description 3
- 229940005581 sodium lactate Drugs 0.000 claims description 3
- 235000011088 sodium lactate Nutrition 0.000 claims description 3
- 229940100515 sorbitan Drugs 0.000 claims description 3
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 claims description 3
- 229940032091 stigmasterol Drugs 0.000 claims description 3
- 235000016831 stigmasterol Nutrition 0.000 claims description 3
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 claims description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 2
- 244000144725 Amygdalus communis Species 0.000 claims description 2
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
- 235000009120 camo Nutrition 0.000 claims description 2
- 235000005607 chanvre indien Nutrition 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000011487 hemp Substances 0.000 claims description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 abstract description 24
- 230000001815 facial effect Effects 0.000 abstract description 5
- 238000009826 distribution Methods 0.000 abstract description 4
- 239000008247 solid mixture Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 78
- 210000003491 skin Anatomy 0.000 description 41
- 238000009472 formulation Methods 0.000 description 32
- 235000019589 hardness Nutrition 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 230000004888 barrier function Effects 0.000 description 9
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 229940042585 tocopherol acetate Drugs 0.000 description 7
- 239000000654 additive Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 150000002191 fatty alcohols Chemical class 0.000 description 5
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- 239000003760 tallow Substances 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 206010000496 acne Diseases 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 210000000245 forearm Anatomy 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000273930 Brevoortia tyrannus Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000035874 Excoriation Diseases 0.000 description 3
- 241000772415 Neovison vison Species 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940126534 drug product Drugs 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000010466 nut oil Substances 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 239000010502 orange oil Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000003784 tall oil Substances 0.000 description 3
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 3
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 241000384508 Hoplostethus atlanticus Species 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 235000004433 Simmondsia californica Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 239000012182 japan wax Substances 0.000 description 2
- 229940001447 lactate Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 239000004170 rice bran wax Substances 0.000 description 2
- 235000019384 rice bran wax Nutrition 0.000 description 2
- 235000019719 rose oil Nutrition 0.000 description 2
- 239000010666 rose oil Substances 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 239000010686 shark liver oil Substances 0.000 description 2
- 229940069764 shark liver oil Drugs 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- 230000037067 skin hydration Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- MQILKRLZMJKIJE-UHFFFAOYSA-N (1-decanoyloxy-3-octanoyloxypropan-2-yl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC)COC(=O)CCCCCCCCC MQILKRLZMJKIJE-UHFFFAOYSA-N 0.000 description 1
- MBZYKEVPFYHDOH-UHFFFAOYSA-N (10S)-3c-Hydroxy-4.4.10r.13t.14c-pentamethyl-17t-((R)-1.5-dimethyl-hexyl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(C)CCCC(C)C)CCC21C MBZYKEVPFYHDOH-UHFFFAOYSA-N 0.000 description 1
- OQWIKYXFAZAALW-FMDYKLJDSA-N (2S)-2-amino-5-oxo-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoic acid Chemical compound N[C@@H](CCC(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(O)=O OQWIKYXFAZAALW-FMDYKLJDSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- UBEIMDKGOYBUKT-FLIQGJDUSA-N 1,2,3-trilinolenoylglycerol Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC)COC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC UBEIMDKGOYBUKT-FLIQGJDUSA-N 0.000 description 1
- HBOQXIRUPVQLKX-BBWANDEASA-N 1,2,3-trilinoleoylglycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COC(=O)CCCCCCC\C=C/C\C=C/CCCCC HBOQXIRUPVQLKX-BBWANDEASA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical class CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- GKLLDHHZSUEWRE-UHFFFAOYSA-N 2,3-bis(18-acetyloxyoctadecanoyloxy)propyl 18-acetyloxyoctadecanoate Chemical compound CC(=O)OCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCOC(C)=O)COC(=O)CCCCCCCCCCCCCCCCCOC(C)=O GKLLDHHZSUEWRE-UHFFFAOYSA-N 0.000 description 1
- QNESDXMHQYMNGD-UHFFFAOYSA-N 2,3-bis(3,5,5-trimethylhexanoyloxy)propyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CC(=O)OCC(OC(=O)CC(C)CC(C)(C)C)COC(=O)CC(C)CC(C)(C)C QNESDXMHQYMNGD-UHFFFAOYSA-N 0.000 description 1
- RIXCYAQOGLLEIU-UINBUCCLSA-N 2,3-bis[[(z,12r)-12-acetyloxyoctadec-9-enoyl]oxy]propyl (z,12r)-12-acetyloxyoctadec-9-enoate Chemical compound CCCCCC[C@@H](OC(C)=O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/C[C@@H](CCCCCC)OC(C)=O)COC(=O)CCCCCCC\C=C/C[C@@H](CCCCCC)OC(C)=O RIXCYAQOGLLEIU-UINBUCCLSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- XVJNMIGVIYENHK-UHFFFAOYSA-N 2-amino-6-[[3,5,6-trihydroxy-2-oxo-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexyl]amino]hexanoic acid Chemical compound OC(=O)C(N)CCCCNCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O XVJNMIGVIYENHK-UHFFFAOYSA-N 0.000 description 1
- FGYZAECYNNGYAN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;propane-1,2-diol Chemical compound CC(O)CO.OC(=O)CC(O)(C(O)=O)CC(O)=O FGYZAECYNNGYAN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MBZYKEVPFYHDOH-BQNIITSRSA-N 24,25-dihydrolanosterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@]21C MBZYKEVPFYHDOH-BQNIITSRSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- WHDZFABLYCTYDP-UHFFFAOYSA-N 5-oxopyrrolidine-2-carboxylate;tris(2-hydroxyethyl)azanium Chemical compound OC(=O)C1CCC(=O)N1.OCCN(CCO)CCO WHDZFABLYCTYDP-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000004507 Abies alba Nutrition 0.000 description 1
- 235000017894 Abies grandis Nutrition 0.000 description 1
- 244000178606 Abies grandis Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000004047 Amorpha fruticosa Nutrition 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001072256 Boraginaceae Species 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 101100224748 Caenorhabditis elegans pir-1 gene Proteins 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- MBXVIRZWSHICAV-UHFFFAOYSA-N Glycerol triundecanoate Chemical compound CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCC)COC(=O)CCCCCCCCCC MBXVIRZWSHICAV-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 241001184005 Hyptis Species 0.000 description 1
- 240000004343 Indigofera suffruticosa Species 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000017945 Matricaria Nutrition 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- RZCHTMXTKQHYDT-UHFFFAOYSA-N N-Lactoyl ethanolamine Chemical compound CC(O)C(=O)NCCO RZCHTMXTKQHYDT-UHFFFAOYSA-N 0.000 description 1
- PVCJKHHOXFKFRP-UHFFFAOYSA-N N-acetylethanolamine Chemical compound CC(=O)NCCO PVCJKHHOXFKFRP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- 241001516747 Pentadesma Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000390166 Physaria Species 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
- 235000001498 Salvia hispanica Nutrition 0.000 description 1
- 240000005481 Salvia hispanica Species 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 241000208829 Sambucus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 240000007591 Tilia tomentosa Species 0.000 description 1
- 235000017654 Torreya californica Nutrition 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 244000025271 Umbellularia californica Species 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UYCAGRPOUWSBIQ-WOYAITHZSA-N [(1s)-1-carboxy-4-(diaminomethylideneamino)butyl]azanium;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound OC(=O)[C@@H]1CCC(=O)N1.OC(=O)[C@@H](N)CCCN=C(N)N UYCAGRPOUWSBIQ-WOYAITHZSA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- ZQTHGEDPCAXWHM-HBKZIJBRSA-N [(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] 2-octyldecanoate Chemical compound C1C[C@@H]2[C@@]3(C)CC[C@H](OC(=O)C(CCCCCCCC)CCCCCCCC)C[C@@H]3CC[C@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@]21C ZQTHGEDPCAXWHM-HBKZIJBRSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- 239000001269 achillea millefolium l. oil Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229940005787 behenyl benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000010623 birch oil Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000010474 borage seed oil Substances 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229940096386 coconut alcohol Drugs 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- IACXYDVFQDGXJF-UHFFFAOYSA-N docosyl benzoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 IACXYDVFQDGXJF-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000001734 eugenia caryophyllata l. bud oleoresin Substances 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 239000010645 fir oil Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 229940055015 glycereth-20 Drugs 0.000 description 1
- 229940088638 glycereth-7 Drugs 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 239000000175 humulus lupulus l. cone oil Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 235000019866 hydrogenated palm kernel oil Nutrition 0.000 description 1
- 239000010512 hydrogenated peanut oil Substances 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 229940082005 hydrogenated tallow acid Drugs 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- SXQFCVDSOLSHOQ-UHFFFAOYSA-N lactamide Chemical compound CC(O)C(N)=O SXQFCVDSOLSHOQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- HBOQXIRUPVQLKX-UHFFFAOYSA-N linoleic acid triglyceride Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000010487 meadowfoam seed oil Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000000457 mentha pulegium l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- 229940031722 methyl gluceth-20 Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 239000010658 moringa oil Substances 0.000 description 1
- 239000010697 neat foot oil Substances 0.000 description 1
- KPWVFNOPNOTYNJ-UHFFFAOYSA-N octadecyl benzoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 KPWVFNOPNOTYNJ-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- HRPZGPXWSVHWPB-UHFFFAOYSA-N octyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCCCCCC HRPZGPXWSVHWPB-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000012168 ouricury wax Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940097407 palm kernel acid Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000012169 petroleum derived wax Substances 0.000 description 1
- 235000019381 petroleum wax Nutrition 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 239000001794 pinus palustris tar oil Substances 0.000 description 1
- 239000001738 pogostemon cablin oil Substances 0.000 description 1
- WKHCFXKQKDNLEB-DFWYDOINSA-M potassium;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [K+].[O-]C(=O)[C@@H]1CCC(=O)N1 WKHCFXKQKDNLEB-DFWYDOINSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001327 prunus amygdalus amara l. extract Substances 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 229940094944 saccharide isomerate Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 239000010671 sandalwood oil Substances 0.000 description 1
- 239000010672 sassafras oil Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000004458 spent grain Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000002641 tar oil Substances 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229940098780 tribehenin Drugs 0.000 description 1
- 229940093633 tricaprin Drugs 0.000 description 1
- 229940093609 tricaprylin Drugs 0.000 description 1
- 229940087291 tridecyl alcohol Drugs 0.000 description 1
- PJHKBYALYHRYSK-UHFFFAOYSA-N triheptanoin Chemical compound CCCCCCC(=O)OCC(OC(=O)CCCCCC)COC(=O)CCCCCC PJHKBYALYHRYSK-UHFFFAOYSA-N 0.000 description 1
- 229940078561 triheptanoin Drugs 0.000 description 1
- 229940057400 trihydroxystearin Drugs 0.000 description 1
- 229940116962 triisononanoin Drugs 0.000 description 1
- 229940098385 triisostearin Drugs 0.000 description 1
- 229940081852 trilinolein Drugs 0.000 description 1
- 229940113164 trimyristin Drugs 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 229960001947 tripalmitin Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8135—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Definitions
- the present invention relates to the inclusion of a lipid-enriched hydrophobic lotion on absorbent tissue products, such as facial tissue, bath tissue, paper towels, and the like. More particularly, the present invention relates to the enhancement of skin barrier function by the delivery of oil based-hydrophobic compositions from the absorbent tissue products to the skin.
- the stratum corneum is the outer-most layer of the skin and is responsible for regulating skin water levels and functioning as a barrier against chemicals and other stressors found in the environment.
- the complex arrangement of lipids in the intercellular space of the stratum corneum is responsible for the establishment of normal barrier function.
- Multi-layered structures of cholesterol, ceramides, and fatty acids, as well as some other minor lipids provide the major barrier to the transport of hydrophillic substances into the or through the skin.
- the link between the barrier function and skin health is apparent from the skin inflammation caused by lipid extraction from the skin.
- Skin barrier can be damaged due to a number of mechanisms. Physical abrasion, for example caused by the repeated rubbing of absorbent tissue products on the skin, strips away layers of the skin and thus damages skin barrier.
- Biological fluids such as urine, feces, nasal and vaginal secretions, may contain a variety of components that can damage skin barrier. Examples of these components include proteases, lipases, bile acids, and fatty acids. Once the skin barrier is compromised, these components, in addition to other constituents of biological fluids, can initiate or exacerbate skin inflammation.
- Excessive hydration also has a negative impact on skin barrier. Frequent contact of the skin with fluids such as nasal secretion can contribute to increased skin hydration. Increased skin hydration disrupts skin lipid organization in the stratum corneum. This disruption may increase the skin permeability of irritants, thus increasing the risk of skin inflammation.
- Absorbent tissue products such as facial tissue and bath tissue have been used to absorb body fluids and leave the skin dry.
- Absorbent tissue in addition to absorbing fluids, however, also abrade the skin during use and frequently do not leave the skin completely dry and free of the body fluid the tissue is trying to absorb. During frequent nose-blowing or perianal wiping, for example, the skin can become so abraded as to appear red and be sore to the touch.
- tissue additive formulations can be applied to the tissue such that, in use, the additive formulation either provides lubricity causing the tissue to glide across the surface of the skin, or leaves the tissue and is deposited on the skin.
- these additive formulations provide a skin benefit by occluding the skin.
- these formulations provide a short-term benefit by providing an artificial barrier, even though the underlying stratum corneum is still damaged.
- formulation chemistry that, when applied from an absorbent tissue, enhances the skin's barrier function by delivering lipid chemistry while minimizing the physical damage caused by the rubbing of the said absorbent tissue on the skin surface.
- a skin barrier-enhancing aborbent tissue product can be made applying, on the tissue.an oil based-hydrophobic composition comprising a natural fat or oil, a sterol or sterol derivative, a humectant, an emulsifying surfactant having an HLB range from about 3 to about 6, an emollient, a wax, and optionally a viscosity enhancer, and thereafter resolidifying the composition to form a distribution, preferably a uniform distribution, of solid deposits on the surface(s) of the tissue. Because the composition is a solid at room temperature and rapidly solidifies after deposition, it has less tendency to penetrate and migrate into the sheet.
- the present invention is an oil based-hydrophobic composition
- an oil based-hydrophobic composition comprising from about 0.1 to about 95 weight percent natural fats or oils, from about 0.1 to about 10 weight percent sterols or sterol derivatives, from about 0.5 to about 20 weight percent of humectant, from about 1 to about 20 weight percent of water-in-oil emulsifying surfactant having an HLB range from about 3 to about 6, from about 5 to about 95 weight percent emollient, from about 5 to about 95 weight percent wax, and optionally from about 0 to about 25 weight percent viscosity enhancer.
- the composition may have a melting point from about 30 °C. to about 100 °C. and a process viscosity of greater than about 50 centipoise.
- the composition may have a penetration hardness of from about 5 millimeters to 360 millimeters.
- the invention resides in a tissue or towel product wherein one or both of the outer surfaces of the product have solidified deposits of an oil based-hydrophobic composition
- an oil based-hydrophobic composition comprising from about 0.1 to about 95 weight percent natural fats or oils, from about 0.1 to about 10 weight percent sterol or sterol derivative, from about 0.5 to about 20 weight percent of humectant, from about 1 to about 20 weight percent of water-in-oil emulsifying surfactant having an HLB range from about 3 to about 6, from about 5 to about 95 weight percent emollient, from about 5 to about 95 weight percent wax, and optionally from about 0 to about 25 weight percent viscosity enhancer.
- the composition may have a melting/freezing point of from about 30 °C. to about 100 °C. and a process viscosity of greater than about 50 centipoise.
- the composition may have a penetration hardness from about 5 millimeters of penetration to 360 millimeters of penetration
- the invention resides in a method of making a tissue or towel product comprising: (a) heating a composition that enhances skin barrier comprising a natural fat or oil, a sterol or sterol derivative, humectant, a water-in-oil emulsifying surfactant having an HBL range from about 3 to about 6, an emollient, a wax, and optionally a viscosity enhancer, to a temperature above the melting point of the composition, causing the composition to melt; (b) uniformly applying the melted composition to one or both surfaces of the tissue or towel web in spaced-apart deposits; and (c) resolidifying the deposits of the melted composition.
- the composition may have a melting point ranging from about 30 °C. to 100 about 100 °C.
- One embodiment of the present invention is a tissue or towel product having two outer surfaces.
- One or both outer surfaces of the product have solidified deposits of a composition that enhances skin barrier.
- the composition may comprise from about 0.1 to about 95 weight percent of natural fats or oils, from about 0.1 to about 10 weight percent of sterols or sterol derivatives, from about 1 to about 20 weight percent of water-in-oil emulsifying surfactant
- HLB HLB range from about 3 to about 6, from about 0.5 to about 20 weight percent of humectant, from about 5 to about 95 weight percent of emollient, from about 5 to aboutft ⁇ weight percent of wax, and from about 0 to about 25 weight percent of viscosity enhancer.
- the composition may have a melting point from about 30 °C to about 100 °C.
- the 115 composition may have a penetration hardness of from about 5 millimeters to about 360 millimeters.
- the add-on amount of the composition is from about 0.5 to about 30 weight percent based on the weight of said product.
- the add-on amount of the composition may also be expressed as from about 0.1 grams per meter squared (g/m 2 ) to about 30 g/m 2 of the tissue or towel product, and more preferably from about 0.5 g/m 2 to about 25 g/m 2 . 120
- the natural fat or oil used in the composition may include sunflower oil, borage oil, or avocado oil.
- the sterol or sterol derivative used in the composition may include soy sterol, cholesterol, or lanasterol.
- the humectant used in the composition may include glycerin, sorbitol, or starch hydrolysate.
- the emulsifying surfactant used in the composition may 125 include sorbitan oleate, sorbitan trioleate or sorbitan stearate.
- the emollient used in the composition may include petrolatum, mineral oil, or stearyl alcohol.
- the wax used in the composition may include cerasin, ozokerite, or microcrystalline wax.
- the viscosity enhancer used in the composition may include ethylene/vinyl acetate copolymer or polyethylene.
- Another embodiment of the present invention is a method of making a tissue or towel 130 product having two outer surfaces comprising: (a) heating a composition that enhances skin barrier comprising a natural fat or oil, sterol or sterol derivative, a humectant, an emulsifying surfactant having an HLB range from about 3 to about 6, an emollient, a wax, and viscosity enhancer, to a temperature above the melting point of the composition, causing the composition to melt; (b) applying the melted composition to one or both surfaces of a tissue 135 or towel web in spaced-apart deposits; and, (c) resolidifying said deposits of the melted composition.
- the composition may have a melting point of from about 30 °C to about 100 °C.
- the resolidified composition may have a penetration hardness of from about 5 to about 360 140 millimeters.
- the melted composition may be applied by printing.
- Another embodiment of the present invention is a skin barrier enhancing composition
- a skin barrier enhancing composition comprising from about 0.1 to about 95 weight percent of natural fats or oils, from about 0.1 to about 10 weight percent of sterol or sterol derivative, from about 1 to about 20 weight percent 145 of water-in-oil emulsifying surfactant having an HLB range from about 3 to about 6, from about 0.5 to about 20 weight percent of humectant, from about 5 to about 95 weight percent of emollient, from about 5 to about 95 weight percent of wax, and from about 0 to about 25 weight percent of viscosity enhancer.
- the composition may have a melting point from about 30 °C. to about 100 °C.
- the resolidified composition may have a penetration hardness of from about 5 millimeters to about 360 millimeters.
- the natural fat or oil of the composition may be selected from the group consisting of: 155 avocado oil, apricot oil, babassu oil, borage oil, camellia oil, canola oil, castor oil, chamomile, coconut oil, corn oil, cottonseed oil, evening primrose oil, hemp seed, hydrogenated cottonseed oil, hydrogenated palm kernal oil, maleated soybean oil, meadowfoam oil, palm kernal oil, phospholipids, rapeseed oil, palmitic acid, stearic acid, linoleic acid, rose hip oil, rose hip oil, safflower, sunflower oil, soybean oil, sweet almond, PROLIPID 141 (proprietary 160 blend of glyceryl stearate, fatty acids, fatty alcohols, and phospholipids), or derivatives of natural fats or oils (such as stearyl alcohol, lauryl alcohol, myristyl alcohol, and benenyl alcohol, and the like), as well as mixtures thereof.
- PROLIPID is commercially available from International Specialty Products located in Wayne, New Jersey. PROLIPID is generally described in U.S. Patent No. 5,849,315 to Rerek et al. which issued December 15, 1998; 165 which is herein incorporated by reference to the extent it is consistent herewith.
- the sterol or sterol derivative of the composition may be selected from the group consisting of: cholesterol, sitosterol, stigmasterol, ergosterol, lanasterol, soy sterol, avocado sterols, sterol esters, and the like, as well as mixtures thereof.
- the emulsifying surfactant of 170 the composition may be selected from the group consisting of: sorbitan oleate, sorbitan sesquioleate, sorbitan stearate, sorbitan tristerate, sorbitan trioleate, and the like, as well as mixtures thereof.
- the humectant of the composition may be selected from the group consisting of: 175 glycerin, hydrogenated starch hydrolysate, propylene glycol, sodium PCA, sodium lactate, sorbitol, and the like, as well as mixtures thereof.
- the emollient of the composition may be selected from the group consisting of: mineral oil, petrolatum, stearyl alcohol, cetearyl alcohol, cetyl alcohol, behenyl alcohol, octyldodecanol, cosmetic esters, and the like, as well as mixtures thereof.
- the wax of the composition may be selected from the group consisting of: carnuba, cerasin, cetyl esters, microcrystalline wax, montan wax, ozokerite, synthetic wax, and the like, as well as mixtures thereof.
- the viscosity enhancer of the composition may be selected from the group consisting of: polyolefms resins, polyolefin polymers, ethylene/vinyl acetate copolymers, polyethylene, and the like, as well as mixtures
- the amount of the natural fats or oils used in the composition may be from about 0.1 to about 95 weight percent.
- the amount of the sterol or sterol derivative used in the composition may be from about 0.1 to about 10 percent.
- the amount of the emulsifying 190 surfactant used in the composition may be from about 1 to about 20 weight percent.
- the amount of the humectant used in the composition may be from about 0.5 to about 20 weight percent.
- the amount of the emollient used in the composition may be from about 5 to about 95 weight percent.
- the amount of the wax used in the composition may be from about 5 to about 95 weight percent.
- the amount of the viscosity enhancer used in the composition may 195 be from about 0 to about 25 weight percent.
- composition comprises about 10 weight percent sunflower oil, about 0.8 weight percent soy sterol, about 1 weight percent sorbitan oleate, about 5 weight percent glycerin, about 43.2 weight percent petrolatum, about 20 weight percent stearyl 200 alcohol, and about 20 weight percent cerasin.
- compositions comprises about 10 weight percent borage oil, about 0.8 weight percent soy sterol, about 1 weight percent sorbitan oleate, about 5 weight percent glycerin, about 43.2 weight percent petrolatum, about 20 weight percent 205 stearyl alcohol, and about 20 weight percent cerasin.
- compositions comprises about 10 weight percent avocado oil, about 0.8 weight percent soy sterol, about 1 weight percent sorbitan oleate, about 5 weight percent glycerin, about 43.2 weight percent petrolatum, about 20 weight percent 210 stearyl alcohol, and about 20 weight percent cerasin.
- compositions comprises about 2 weight percent PROLIPID 141 (International Specialty Products, Wayne, New Jersey), about 10 weight percent sunflower oil, about 1 weight percent soy sterol, about 1 weight percent sorbitan oleate, about 215 5 weight percent glycerin, about 32 weight percent petrolatum, about 15 weight percent behenyl alcohol, about 32 weight percent cerasin, and about 2 weight percent viscosity polyethylene.
- PROLIPID 141 International Specialty Products, Wayne, New Jersey
- sunflower oil about 1 weight percent soy sterol
- sorbitan oleate about 215 5 weight percent glycerin
- about 32 weight percent petrolatum about 15 weight percent behenyl alcohol
- cerasin about 2 weight percent viscosity polyethylene.
- compositions comprises about 2 weight percent PROLIPID 220 141 (International Specialty Products, Wayne, New Jersey), about 30 weight percent sunflower oil, about 3 weight percent soy sterol, about 5 weight percent sorbitan oleate, about 5 weight percent sorbitol, about 10 weight percent petrolatum, about 10 weight percent behenyl alcohol, about 30 weight percent ozokerite, and about 5 weight percent polyethylene.
- PROLIPID 220 141 International Specialty Products, Wayne, New Jersey
- sunflower oil about 3 weight percent soy sterol
- soy sterol about 5 weight percent sorbitan oleate
- sorbitol about 10 weight percent petrolatum
- behenyl alcohol about 30 weight percent ozokerite
- polyethylene polyethylene
- composition comprises about 5 weight percent lanolin, about 20 weight percent sunflower oil, about 3 weight percent cholesterol, about 5 weight percent sorbitan stearate, about 5 weight percent hydrogenated starch hydrolysate, about 2 weight percent petrolatum, about 5 weight percent octyldodecanol , about 15 weight percent stearyl alcohol, about 30 weight percent microcrystalline wax, and about 5 weight percent
- compositions comprises about 27 weight percent avocado oil, about 3 weight percent avocadin or avocado sterols, about 2 weight percent sorbitan trioleate, about 15 weight percent glycerin, about 17 weight percent petrolatum, about 18 235 weight percent cetyl alcohol, and about 18 weight percent cerasin.
- compositions comprises about 15 weight percent avocado oil, about 5 weight percent sterol esters, about 10 weight percent sorbitan trioleate, about 8 weight percent glycerin, about 2 weight percent petrolatum, about 55 weight percent of a 240 blend of ozokerite and cetyl esters, and about 5 weight percent polyethylene.
- the blend of ozokerite and cetyl esters comprises about 90 weight percent ozokerite and about 10 weight percent cetyl esters.
- compositions comprises about 25 weight percent borage 245 oil, about 10 weight percent avocadin or avocado sterols, about 5 weight percent sorbitan trioleate, about 1 weight percent glycerin, about 11 weight percent petrolatum, about 10 weight percent stearyl alcohol, about 36 weight percent cerasin, and about 2 weight percent polyethylene.
- composition comprises about 25 weight percent sunflower oil, about 3 weight percent lanasterol, about 2 weight percent sorbitan trioleate, about 5 weight percent glycerin, about 15 weight percent petrolatum, about 10 weight percent stearyl alcohol, about 10 weight percent behenyl alcohol, about 45 weight percent microcrystallin wax, and about 5 weight percent polyethylene.
- compositions comprises about 35 weight percent avocado oil, about 3 weight percent sitosterol about 5 weight percent sorbitan trioleate, about 5 weight percent glycerin, about 1 weight percent petrolatum, about 10 weight percent stearyl alcohol, about 21 weight percent ozokerite, and about 10 weight percent polyethylene.
- Another embodiment of the present invention is a method for enhancing/restoring/maintaining the skin barrier function of a user.
- the method comprises the steps of: a) contacting a tissue or towel product on the skin of said user wherein said
- 265 material comprises a skin barrier enhancing/restoring/maintaining composition that provides a skin barrier enhancing/restoring/maintaining benefit upon transfer of the composition to the user's skin; b) transferring at least a portion of the composition during use of the tissue or towel product;
- 270 c) repeating steps a) and b) with one or more additional tissue or towel product with sufficient frequency to enhance/restore/maintain the skin barrier in an area of skin contacted by the tissue or towel product, relative to skin contacted by an equivalent tissue or towel product that does not comprise the skin barrier enhancing/restoring/maintaining composition.
- the skin barrier enhancing/restoring/maintaining composition of the method comprises from about 0.1 to about 95 weight percent of natural fats or oils, from about 0.1 to about 10 weight percent of sterols and sterol derivatives, from about 1 to about 20 weight percent of water-in- oil emulsifying surfactant having an HLB range from about 3 to about 6, from about 0.5 to about 20 weight percent of humectant, from about 5 to about 95 weight percent of emollient, 280 from about 5 to about 95 weight percent of wax, and from about 0 to about 25 weight percent of viscosity enhancer.
- the composition may have a melting point from about 30 °C. to about 100 °C.
- the resolidified composition may have a process viscosity greater than about 50 centipoise.
- 285 resolidified composition may have a penetration hardness of from about 5 to about 360 millimeters.
- the method may further comprise using a tissue or towel product having a skin- barrier enhancing/restoring/maintaining composition by the user on each use occasion.
- the method may further comprise using a tissue or towel product which does not comprise a skin- barrier enhancing/restoring/maintaining composition by the user intermittently.
- tissue or towel product comprising a skin-barrier enhancing/restoring/maintaining composition by a user whose skin is compromised and with sufficient frequency to improve skin-barrier function.
- the amount of a natural fat or oil or a mixture of natural fats or oils in the oil based- 295 hydrophobic composition can be from about 0.1 to about 95 weight percent, more specifically from about 5 to about 75 weight percent, more specifically from about 10 to about 50 weight percent.
- natural fats or oils is understood to include fats, oils, essential oils, fatty acids, fatty alcohols, phospholipids, and mixtures thereof.
- suitable natural fats or oils include, but are not limited to, the following materials classified 300 according to CTFA designations:
- Fats and Oils Apricot Kernel Oil, Avocado Oil, Babassu Oil, Borage Seed Oil, Butter, C 12 -C 18 Acid Triglyceride, Camellia Oil, Canola Oil, Caprylic/Capric/Lauric Triglyceride, Caprylic/Capric/Linoleic Triglyceride, Caprylic/Capric/Stearic Triglyceride, Caprylic/Capric
- Triglyceride Carrot Oil, Cashew Nut Oil, Castor Oil, Cherry Pit Oil, Chia Oil, Cocoa Butter, coconut Oil, Cod Liver Oil, Corn Germ Oil, Corn Oil, Cottonseed Oil, C 10 -C 18 Triglycerides, Egg Oil, Epoxidized Soybean Oil, Evening Primrose Oil, Glyceryl Triacetyl Hydroxystearate, Glyceryl Triacetyl Ricinoleate, Glycosphingolipids, Grape Seed Oil, Hazelnut Oil, Human Placental Lipids, Hybrid Safflower Oil, Hybrid Sunflower Seed Oil, Hydrogenated Castor Oil,
- Fatty Acids Arachidic Acid, Arachidonic Acid, Behenic Acid, Capric Acid, Caproic Acid, 330 Caprylic Acid, Coconut Acid, Corn Acid, Cottonseed Acid, Hydrogenated Coconut Acid,
- Fatty Alcohols Behenyl Alcohol, Alcohols, C 12 -C 13 Alcohols, C 12 -C 15 Alcohols, C 12 -C 16 Alcohols, C 14 -C 15 Alcohols, Caprylic Alcohol, Cetearyl Alcohol, Cetyl Alcohol, coconut Alcohol, Decyl Alcohol, Hydrogenated Tallow Alcohol, Lanolin Alcohol, Lauryl Alcohol, 340 Myristyl Alcohol, Oleyl Alcohol, Palm Alcohol, Palm Kernel Alcohol, Stearyl Alcohol, Tallow Alcohol, Tridecyl Alcohol, and the like, as well as mixtures thereof.
- Essential Oils Anise Oil, Balm Mint Oil, Basil Oil, Bee Balm Oil, Bergamot Oil, Birch Oil, Bitter Almond Oil, Bitter Orange Oil, Calendula Oil, California Nutmeg Oil, Caraway Oil,
- the preferred natural oils include, but not limited to: Avocado Oil, Apricot Oil, Babassu Oil, Borage Oil, Camellia oil, Canola oil, Castor Oil, coconut oil, Corn Oil, Cottonseed Oil, Evening Primrose Oil, Hydrogenated Cottonseed Oil, Hydrogenated Palm Kernal Oil, Maleated Soybean Oil, Meadowfoam Oil, Palm Kernal Oil, Phospholipids,
- Soybean Oil Soybean Oil, PROLIPID 141 (proprietary blend of Glyceryl Stearate, Fatty Acids, Fattty Alcohols , and Phospholipids from International Specialty Products, Wayne, New Jersey), derivatives of natural fats or oils (such as Stearyl Alcohol, Lauryl Alcohol, Myristyl Alcohol, Benenyl Alcohol, and the like), and the like, as well as mixtures thereof.
- the amount of a sterol or sterol derivative or mixture of sterols or sterol derivatives in the oil based-hydrophobic composition can be from about 0.1 to about 10 weight percent, more specifically from about 0.5 to about 5 weight percent, and still more specifically from about 0.8 to about 1 weight percent.
- suitable sterols and sterol derivatives can be from about 0.1 to about 10 weight percent, more specifically from about 0.5 to about 5 weight percent, and still more specifically from about 0.8 to about 1 weight percent.
- ⁇ -sterols having a tail on the 17 position and having no polar groups for example cholesterol, sitosterol, stigmasterol, and ergosterol, as well as C 10 -C 30 cholesterol/lanosterol esters, cholecalciferol, cholesteryl hydroxystearate, cholesteryl isostearate, cholesteryl stearate, 7-dehydrocholesterol, dihydrocholesterol, dihydrocholesteryl octyldecanoate, dihydrolanosterol, dihydrolanosteryl
- the amount of water-in-oil emulsifying surfactant/surfactant combinations having an 380 HLB range from about 3 to about 6 in the oil based-hydrophobic composition can be from about 1 to about 20 weight percent, more specifically from about 2 to about 10 weight percent, and still more specifically from about 3 to about 8 weight percent.
- Emulsifying surfactants are employed typically in cosmetic preparations to form emulsions of various components.
- the immiscible phase, such as water and water soluble/dispersible materials, 385 is dispersed as droplets in the continuous phase, such as an oil.
- the preferred surfactants include, but are not limited to: Sorbitan monooleate, glyceryl stearate, sorbitan sequioleate, sorbitan trioleate, sorbitan stearate, sorbitan tristearate, and the like, as well as mixtures thereof.
- the amount of humectant in the oil based-hydrophobic composition can be from about 0.5 to about 20 weight percent, more specifically from about 1 to about 15 weight percent, and still more specifically from about 3 to about 10 weight percent.
- Humectants are typically cosmetic ingredients used to increase the water content of the tip layers of the skin. This
- suitable humectants include, but are not limited to, the following materials: Acetamide MEA, Aloe Vera Gel, Arginine PCA, Chitosan PCA, Copper PCA, Corn Glycerides, Dimethyl Imidazolidinone, Fructose, Glucamine, Glucose, Glucose Glutamate, Glucuronic Acid, Glutamic Acid, Glycereth-7, Glycereth-12, Glycereth-20, Glycereth-26, Glycerin, Honey,
- the preferred humectants include, but are not limited to: Glycerin, Hydrogenated Starch Hydrolysate, Propylene glycol, Sodium PCA, Sodium Lactate, Sorbitol and the like, as well as mixtures thereof.
- the amount of emollient in the oil based-hydrophobic composition may be from about
- suitable emollients include, but are not limited to, the following materials: mineral oil, mineral jelly, petrolatum, cosmetic esters (isoproyl palmitate, isopropyl myristate, isopropyl adipate, C 12 -C 14
- the preferred emollients include, but are not limited to: Mineral Oil, Petrolatum, cosmetic esters, fatty alcohols and the like, as well as mixtures thereof.
- the amount of wax in the oil based-hydrophobic composition can be from about 5 to 425 about 95 weight percent, more specifically from about 10 to about 75 weight percent, and still more specifically from about 20 to about 60 weight percent.
- suitable waxes include, but are not limited to, the following materials: natural and synthetic waxes, such as bayberry wax, beeswax, C 30 alkyl dimethicone, candelilla wax, camuaba, ceresin, setyl esters, hydrogenated cottonseed oil, hydrogenated jojoba oil, hydrogenated jojoba wax, 430 hydrogenated microcrystalline wax, hydrogenated rice bran wax, japan wax, jojoba butter, jojoba esters, jojoba wax, lanolin wax, microcrystalline wax, mink wax, montan acid wax, montan wax, ouricury wax, ozokerite, paraffin, PEG-6 beeswax, PEG-8 beeswax, rice bran wax, shellac wax, spent grain wax,
- the preferred waxes include but are not limited to: carnuba, cerasin, cetyl esters, microcrystalline wax, montan wax, ozokerite, synthetic wax, and the like, as well as mixtures thereof.
- the amount of viscosity enhancer in the oil based-hydrophobic composition can be from about 0 to about 25 weight percent, more specifically from about 5 to about 20 weight percent, and still more specifically from about 10 to about 15 weight percent.
- suitable viscosity enhancers include, but are not limited to, the following materials: the
- polystyrene resins consisting of polyolefins resins, polyolefin polymers, ethylene/vinyl acetate copolymers, polyethylene and the like, as well as mixtures thereof.
- Resolidification of the melted oil based-hydrophobic composition can occur almost instantaneously, without the need for external cooling means such as chill rolls, if the 450 composition is heated to a temperature only slightly above or at the melting point of the composition.
- external means such as chill rolls, either before or after the application of melt, can be used if desired to accelerate resolidification.
- Such instantaneous resolidification tends to impede penetration of the composition into the tissue and retain it on the surface of the tissue, which is advantageous. For example, the temperature of the
- melted composition can advantageously be above the melting point about 10 °C. or less, more specifically about 5 °C. or less and still more specifically about 2 °C. or less. As the temperature of the melted composition approaches the melting point, the viscosity of the melted composition generally increases, which further enhances the tendency of the melted composition to be retained on the surface.
- melting point is the temperature at which the majority of the melting occurs, it being recognized that melting actually occurs over a range of temperatures.
- the melting point of the compositions of this invention can be from about 30 °C. to about 100 °C, more specifically from about 40 °C. to about 90 °O, and still more specifically from about
- penetration hardness is the needle penetration in millimeters according to ASTM D 1321 , “Needle Penetration of Petroleum Waxes. Lower needle penetration hardness values correspond to harder materials.
- compositions of this invention can be from about 5 to 360 millimeters, more specifically from about 5 to about 200 millimeters, more specifically from about 5 to about 150 millimeters, and still more specifically from about 5 to about 00 millimeters. (Formulations having a needle penetration hardness greater than 360 millimeters cannot be measured using ASTM method D 1321).
- the hardness of the formulations of this invention is important for two reasons. First, the softer the formulation the more mobile the formulation will be, making the formulation more likely to migrate to the inner plies of the tissue, which is not desirable. Secondly, softer formulations tend to be more greasy/oily to the touch, which is also less desirable. In
- melt point viscosity and/or the process temperature viscosity of the formulations or compositions of this invention is important for two reasons: First, the higher the melt point viscosity or the process temperature viscosity as it is applied to the outside surface of the diaper liner, the formulation is less likely to penetrate through to the inner ply(s) of the tissue. The less formulation penetrates through the tissue, the more there is on the surface of the
- antiacne actives a drug product used to reduce the number of acne blemishes, acne pimples, blackheads, and whiteheads
- antifoaming agents reduce the tendency of foaming during processing
- antimicrobial actives antifungal actives
- antiseptic actives antioxidants (product integrity to prevent oxidation of the natural oils or other formulation ingredients);
- astringents - cosmetic induce a tightening or tingling sensation on skin
- astringent - drug a drug product which checks oozing, discharge, or bleeding when applied to skin or mucous membrane and works by coagulating protein
- biological additives enhance the performance or consumer appeal of the product including vitamins); colorants (impart color to the product); deodorants (reduce or eliminate unpleasant odor and protect against the formation
- emollients help to maintain the soft, smooth, and pliable appearance of the skin by their ability to remain on the skin surface or in the stratum corneum to act as lubricants, to reduce flaking, and to improve the skin's appearance
- film formers to hold active ingredients on the skin by producing a continuous film on skin upon drying
- fragrances consumer appeal
- natural moisturizing agents NMF
- moisturizing ingredients known in the art; skin conditioning agents; skin exfoliating agents (ingredients that increase the rate of skin cell turnover such as alpha hydroxy acids and beta hydroxyacids); skin protectants (a drug product which protects injured or exposed skin or mucous membrane surface from harmful or annoying stimuli); solvents (liquids employed to dissolve components found useful in the cosmetics or drugs); sunscreens (ingredients that
- UV 515 absorb at least 85 percent of the light in the UV range at wavelengths from 290 to 420 manometers, but transmit UV light at wavelengths longer than 420 manometers); and, surfactants (as cleansing agents, solubilizing agents, suspending agents, and wetting agents).
- the total tissue add-on of the composition can be from about 0.5 to about 40 weight percent, more specifically from about 5 to about 30 weight percent, and more specifically from about 10 to about 15 weight percent, based on the weight of the tissue.
- the add-on amount will depend upon the desired effect of the composition on the product attributes and the specific composition. A preferred method to uniformly apply the heated composition to
- the surface of the tissue web is rotogravure printing, either direct or indirect (offset), because it is a more precise exact printing process and offers maximum control of the composition distribution and transfer rate.
- rotogravure printing either direct or indirect (offset)
- other printing methods but not limited to, flexographic printing or spraying such as WEKO, can be used.
- compositions of the present invention may be applied to the entire outer 535 surface(s) of the tissue or towel product or portions thereof.
- the compositions of the present invention may be applied non-uniformly to the outer surface of the tissue or towel product.
- non-uniformly refers to the amount, pattern of distribution, thickness of the application, areas of non-coverage, or the like, for which the composition can be varied over the outer surface(s) of the tissue or towel product.
- tissue product can be a facial tissue, bath tissue, paper towel, dinner napkin or the like.
- the tissue products of this invention can be one-ply, two-ply, three- ply or more.
- the composition is applied to one or both outer surfaces of the product after the product has been dried.
- the composition can be applied after the plies are 545 brought together or prior to bringing the plies together.
- the individual plies can be layered or blended (homogeneous) creped or uncreped, throughdried or wet-pressed. Examples
- PROLIPID 141 1.0%
- PROLIPID 141 (ISP) 1.0%
- Vitamin E acetate 0.1%
- Vitamin E acetate 0.1%
- Lipid-enriched formulations for treatment of absorbent tissue promote barrier repair as measured by TEWL..
- TEWL Transepidermal water loss
- the volar forearm of 24 panelists was abraded by an emery cloth to increase TEWL levels to 18-20 g/m 2 h. After abrasion, fifteen microliters of a lipid-enriched formulation was topically applied to the volar forearm.
- TEWL measurements were obtained using a Dermalab evaporimeter instrument at 1 , 2, and 4 hours. Mean TEWL values are expressed in Table 1. 645 Repeated measures ANOVA was used to adjust for the repeated TEWL measures.
- Lipid-enriched formulations for treatment of absorbent tissue enhance skin moisturization as measured by conductance.
- Lipid-enriched formulations for treatment of absorbent tissue enhance skin moisturization as measured by conductance.
- Absorbent tissue treated with a hydrophobic lipid-enriched formula was repetitively wiped on the side of the face to determine the extent of barrier damage as measured by
- TEWL 705 TEWL.
- the study consisted of repetitively wiping the face of 10 panelists with the absorbent tissues for a total of 15 wiping cycles. The wiping cycles were timed to be approximately 30 minutes apart with each wiping cycle consisting of 20 wipes. A baseline TEWL reading and TEWL readings after every two wiping cycles were obtained for each panelist using the Dermalab evaporimeter. The change in TEWL between wiping cycles was determined for
- the lipid-enriched hydrophobic composition of the present invention may provide absorbent tissue products having improved
- the different aspects of the present invention can advantageously provide absorbent tissue products which, when compared to conventional tissue products, are softer and have improved protection of skin barrier function.
- absorbent tissue products can advantageously be used for absorbent tissue products, such as facial tissue, bath tissue,
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Laminated Bodies (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10084458T DE10084458T1 (en) | 1999-04-23 | 2000-04-20 | Absorbent tissue to improve the skin's protective layer |
BR0009348-3A BR0009348A (en) | 1999-04-23 | 2000-04-20 | Tissue or towel product with two outer surfaces, process for making them, and skin barrier-improving composition |
GB0125796A GB2366203B (en) | 1999-04-23 | 2000-04-20 | Absorbent tissues providing skin barrier enhancement |
AU44896/00A AU4489600A (en) | 1999-04-23 | 2000-04-20 | Absorbent tissues providing skin barrier enhancement |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13090099P | 1999-04-23 | 1999-04-23 | |
US60/130,900 | 1999-04-23 | ||
US37977799A | 1999-08-24 | 1999-08-24 | |
US09/379,777 | 1999-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000064407A1 true WO2000064407A1 (en) | 2000-11-02 |
Family
ID=26828946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/011089 WO2000064407A1 (en) | 1999-04-23 | 2000-04-20 | Absorbent tissues providing skin barrier enhancement |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR100676794B1 (en) |
AR (1) | AR023933A1 (en) |
AU (1) | AU4489600A (en) |
BR (1) | BR0009348A (en) |
CO (1) | CO5160280A1 (en) |
DE (1) | DE10084458T1 (en) |
GB (1) | GB2366203B (en) |
TW (1) | TWI252110B (en) |
WO (1) | WO2000064407A1 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6475197B1 (en) | 1999-08-24 | 2002-11-05 | Kimberly-Clark Worldwide, Inc. | Absorbent articles having skin health benefits |
FR2829390A1 (en) * | 2001-09-12 | 2003-03-14 | Rocher Yves Biolog Vegetale | Use of plant, yeast or fungal lipid extracts containing ergosterol in cosmetic compositions for enhancing the barrier function of the skin |
US6534074B2 (en) | 1999-08-24 | 2003-03-18 | Kimberly-Clark Worldwide, Inc. | Absorbent articles providing skin health benefits |
WO2002051456A3 (en) * | 2000-12-22 | 2003-06-05 | Kimberly Clark Co | Absorbent articles with non-aqueous compositions containing botanicals |
US6756520B1 (en) | 2000-10-20 | 2004-06-29 | Kimberly-Clark Worldwide, Inc. | Hydrophilic compositions for use on absorbent articles to enhance skin barrier |
WO2004087092A1 (en) * | 2003-03-28 | 2004-10-14 | The Procter & Gamble Company | Tacky skin care compositions and articles having tacky skin care compositions disposed thereon |
US6860967B2 (en) | 2001-01-19 | 2005-03-01 | Sca Hygiene Products Gmbh | Tissue paper penetrated with softening lotion |
WO2005034887A1 (en) * | 2003-09-11 | 2005-04-21 | Kimberly-Clark Worldwide, Inc. | Lotioned tissue product with improved stability |
US6896766B2 (en) | 2002-12-20 | 2005-05-24 | Kimberly-Clark Worldwide, Inc. | Paper wiping products treated with a hydrophobic additive |
US6905697B2 (en) | 2001-01-19 | 2005-06-14 | Sca Hygiene Products Gmbh | Lotioned fibrous web having a short water absorption time |
WO2005110354A1 (en) * | 2004-04-30 | 2005-11-24 | Kimberly-Clark Worldwide, Inc. | Pre-wipes for improving anal cleansing |
EP1757261A3 (en) * | 2001-07-13 | 2008-06-11 | JOHNSON & JOHNSON GmbH | Products comprising a sheet and a lipid and aqueous phase |
KR100871521B1 (en) * | 2001-08-02 | 2008-12-05 | 캠브리지 플랫 프로젝션 디스플레이스 리미티드 | Flat-panel display device using tapered waveguide and manufacturing method thereof |
US7547443B2 (en) | 2003-09-11 | 2009-06-16 | Kimberly-Clark Worldwide, Inc. | Skin care topical ointment |
US7771735B2 (en) | 2000-12-22 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with compositions for reducing irritation response |
US7998495B2 (en) | 2004-06-04 | 2011-08-16 | Kimberly-Clark Worldwide, Inc. | Antimicrobial tissue products with reduced skin irritation potential |
CN109394628A (en) * | 2018-12-13 | 2019-03-01 | 株洲千金药业股份有限公司 | A kind of soft towel of skin care cotton of the fiber containing sunflower and preparation method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109518456A (en) * | 2017-09-20 | 2019-03-26 | 源懋兴业股份有限公司 | Hydrophobic composition, method for using hydrophobic composition, and hydrophobic cloth |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59227816A (en) * | 1983-06-08 | 1984-12-21 | Kao Corp | Skin cleansing and wiping agent composition |
US4690821A (en) * | 1984-02-10 | 1987-09-01 | Creative Products Resource Associates, Ltd. | Towel for skin moisturizing and drying |
WO1999012519A1 (en) * | 1997-09-05 | 1999-03-18 | The Procter & Gamble Company | Cleansing and conditioning products for skin or hair with improved deposition of conditioning ingredients |
WO1999013861A1 (en) * | 1997-09-12 | 1999-03-25 | The Procter & Gamble Company | Cleansing and conditioning article for skin or hair |
-
2000
- 2000-04-14 AR ARP000101762A patent/AR023933A1/en not_active Application Discontinuation
- 2000-04-18 TW TW089107261A patent/TWI252110B/en not_active IP Right Cessation
- 2000-04-19 CO CO00028944A patent/CO5160280A1/en unknown
- 2000-04-20 WO PCT/US2000/011089 patent/WO2000064407A1/en active IP Right Grant
- 2000-04-20 BR BR0009348-3A patent/BR0009348A/en not_active IP Right Cessation
- 2000-04-20 DE DE10084458T patent/DE10084458T1/en not_active Withdrawn
- 2000-04-20 KR KR1020017013466A patent/KR100676794B1/en not_active Expired - Fee Related
- 2000-04-20 AU AU44896/00A patent/AU4489600A/en not_active Abandoned
- 2000-04-20 GB GB0125796A patent/GB2366203B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59227816A (en) * | 1983-06-08 | 1984-12-21 | Kao Corp | Skin cleansing and wiping agent composition |
US4690821A (en) * | 1984-02-10 | 1987-09-01 | Creative Products Resource Associates, Ltd. | Towel for skin moisturizing and drying |
WO1999012519A1 (en) * | 1997-09-05 | 1999-03-18 | The Procter & Gamble Company | Cleansing and conditioning products for skin or hair with improved deposition of conditioning ingredients |
WO1999013861A1 (en) * | 1997-09-12 | 1999-03-25 | The Procter & Gamble Company | Cleansing and conditioning article for skin or hair |
Non-Patent Citations (1)
Title |
---|
DATABASE CHEMICAL ABSTRACTS STN; XP002147160 * |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6475197B1 (en) | 1999-08-24 | 2002-11-05 | Kimberly-Clark Worldwide, Inc. | Absorbent articles having skin health benefits |
US6534074B2 (en) | 1999-08-24 | 2003-03-18 | Kimberly-Clark Worldwide, Inc. | Absorbent articles providing skin health benefits |
US6756520B1 (en) | 2000-10-20 | 2004-06-29 | Kimberly-Clark Worldwide, Inc. | Hydrophilic compositions for use on absorbent articles to enhance skin barrier |
US7771735B2 (en) | 2000-12-22 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with compositions for reducing irritation response |
WO2002051456A3 (en) * | 2000-12-22 | 2003-06-05 | Kimberly Clark Co | Absorbent articles with non-aqueous compositions containing botanicals |
US6749860B2 (en) | 2000-12-22 | 2004-06-15 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with non-aqueous compositions containing botanicals |
US6905697B2 (en) | 2001-01-19 | 2005-06-14 | Sca Hygiene Products Gmbh | Lotioned fibrous web having a short water absorption time |
US6860967B2 (en) | 2001-01-19 | 2005-03-01 | Sca Hygiene Products Gmbh | Tissue paper penetrated with softening lotion |
EP1757261A3 (en) * | 2001-07-13 | 2008-06-11 | JOHNSON & JOHNSON GmbH | Products comprising a sheet and a lipid and aqueous phase |
KR100871521B1 (en) * | 2001-08-02 | 2008-12-05 | 캠브리지 플랫 프로젝션 디스플레이스 리미티드 | Flat-panel display device using tapered waveguide and manufacturing method thereof |
FR2829390A1 (en) * | 2001-09-12 | 2003-03-14 | Rocher Yves Biolog Vegetale | Use of plant, yeast or fungal lipid extracts containing ergosterol in cosmetic compositions for enhancing the barrier function of the skin |
US6896766B2 (en) | 2002-12-20 | 2005-05-24 | Kimberly-Clark Worldwide, Inc. | Paper wiping products treated with a hydrophobic additive |
WO2004087092A1 (en) * | 2003-03-28 | 2004-10-14 | The Procter & Gamble Company | Tacky skin care compositions and articles having tacky skin care compositions disposed thereon |
GB2420282B (en) * | 2003-09-11 | 2007-08-15 | Kimberly Clark Co | Lotioned tissue product with improved stability |
GB2420282A (en) * | 2003-09-11 | 2006-05-24 | Kimberly Clark Co | Lotioned tissue product with improved stability |
US7485373B2 (en) | 2003-09-11 | 2009-02-03 | Kimberly-Clark Worldwide, Inc. | Lotioned tissue product with improved stability |
US7547443B2 (en) | 2003-09-11 | 2009-06-16 | Kimberly-Clark Worldwide, Inc. | Skin care topical ointment |
WO2005034887A1 (en) * | 2003-09-11 | 2005-04-21 | Kimberly-Clark Worldwide, Inc. | Lotioned tissue product with improved stability |
WO2005110354A1 (en) * | 2004-04-30 | 2005-11-24 | Kimberly-Clark Worldwide, Inc. | Pre-wipes for improving anal cleansing |
US7998495B2 (en) | 2004-06-04 | 2011-08-16 | Kimberly-Clark Worldwide, Inc. | Antimicrobial tissue products with reduced skin irritation potential |
CN109394628A (en) * | 2018-12-13 | 2019-03-01 | 株洲千金药业股份有限公司 | A kind of soft towel of skin care cotton of the fiber containing sunflower and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR100676794B1 (en) | 2007-02-01 |
AU4489600A (en) | 2000-11-10 |
GB2366203A (en) | 2002-03-06 |
KR20020030266A (en) | 2002-04-24 |
GB2366203B (en) | 2004-04-07 |
DE10084458T1 (en) | 2002-04-25 |
CO5160280A1 (en) | 2002-05-30 |
TWI252110B (en) | 2006-04-01 |
BR0009348A (en) | 2002-02-05 |
GB0125796D0 (en) | 2001-12-19 |
AR023933A1 (en) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6287581B1 (en) | Absorbent articles providing skin health benefits | |
US6534074B2 (en) | Absorbent articles providing skin health benefits | |
US20030077962A1 (en) | Absorbent tissues providing skin barrier enhancement | |
WO2000064407A1 (en) | Absorbent tissues providing skin barrier enhancement | |
RU2246319C2 (en) | Wet napkins favorably treating skin | |
CA2296363C (en) | Soft tissue achieved by applying a solid hydrophilic lotion | |
AU766971B2 (en) | Wet wipes having skin health benefits | |
US6475197B1 (en) | Absorbent articles having skin health benefits | |
US5849315A (en) | Emulsifier composition for skin care formulations | |
WO2000064501A1 (en) | Skin-friendly absorbent articles and compositions | |
WO2000064409A1 (en) | Skin barrier enhancing absorbent tissues | |
CN100581531C (en) | combination | |
JPS6137710A (en) | Emulsified composition | |
MXPA01009992A (en) | Absorbent tissues providing skin barrier enhancement | |
JP4036313B2 (en) | O / W cream emulsified cosmetic | |
JP2006321769A (en) | Water-in-oil type emulsified cosmetic with high water content | |
MXPA01010761A (en) | Skin barrier enhancing absorbent tissues | |
ZA200107953B (en) | Wet wipes having skin health benefits. | |
MXPA01010759A (en) | Skin-friendly absorbent articles and compositions | |
MXPA00001603A (en) | Soft tissue achieved by applying a solid hydrophilic lotion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/009992 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017013466 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 200125796 Country of ref document: GB Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 0125796.3 Country of ref document: GB |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017013466 Country of ref document: KR |
|
RET | De translation (de og part 6b) |
Ref document number: 10084458 Country of ref document: DE Date of ref document: 20020425 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10084458 Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1020017013466 Country of ref document: KR |